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Abstract. Heat shock protein 47 (HSP47), a collagen- 
specific stress protein, has been postulated to be a col- 
lagen-specific molecular chaperone localized in the ER. 
We previously demonstrated that HSP47 transiently as- 
sociated with newly synthesized procollagen in the ER 
(Nakai, A., M. Satoh, K. Hirayoshi, and K. Nagata. 
1992. J. Cell Biol. 117:903-914).  In the present work, we 
examined the location where HSP47 binds to and disso- 
ciates from newly synthesized procollagen within the 
cells, and whether HSP47 associates with nascent single 
procollagen polypeptide chains and/or with mature tri- 
ple-helix procollagen. This was accomplished by bio- 
chemical coprecipitation with anti-HSP47 and anticol- 
lagen antibodies, combined with pulse-label and chase 
experiments in the presence or absence of various in- 
hibitors for protein secretion, as well as by confocal la- 
ser microscopic observation of the cells double stained 
with both antibodies. We further examined whether the 
RDEL (Arg-Asp-Glu-Leu) sequence at the COOH 
terminus of HSP47 can act as an ER-retention signal, as 
the KDEL sequence does. 
When the secretion of procollagen was inhibited by 
the presence of e~, ed-dipyridyl, an iron chelator that in- 
hibits procollagen triple-helix formation, or by the pres- 
ence of brefeldin A, which inhibits protein transport 
between the ER and the Golgi apparatus, procollagen 
was found to be bound to HSP47 during the chase pe- 
riod in the intermediate compartment. In contrast, the 
dissociation of procollagen chains from HSP47 was not 
inhibited when procollagen secretion was inhibited by 
monensin or bafilomycin A1, both of which are known 
to be inhibitors of post-cis-Golgi transport. These find- 
ings suggest that HSP47 and procollagen dissociated 
between the post-ER and the cis-Golgi compartments. 
HSP47 was shown to bind to nascent, single-polypep- 
tide chains of newly synthesized procollagen, as well as 
to the mature triple-helix form of procollagen. HSP47 
with the RDEL sequence deleted was secreted out of 
the cells, which suggests that the RDEL sequence actu- 
ally acts as an ER-retention signal, as the KDEL se- 
quence does. This secreted HSP47 did not acquire en- 
dogycosidase H resistance. The biological significance 
of the interaction between HSP47 and procollagen in 
the central secretory pathway, as well as possible mech- 
anisms for this pathway, will be discussed. 
N 
EWLY synthesized membrane and  secretory pro- 
teins are translocated across the ER membrane 
and are then transported to the Golgi apparatus 
for subsequent distribution to the cell surface, lysosomes, 
and secretory vesicles. Many of these proteins are not ex- 
ported from the ER until they are folded and assembled 
correctly (Hurtley and Helenius, 1989). The ER contains 
several  ER-resident proteins that are termed "molecular 
chaperones" or "folding enzymes." These molecular chap- 
erones are involved in the processing  and maturation of 
secretory and membrane proteins; they are thought to as- 
sociate with folding intermediates or misfolded proteins to 
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prevent nonproductive side reactions such as irreversible 
aggregation,  and they may accelerate the slower steps in 
the folding process (for reviews see Hurtley and Helenius, 
1989; De Silva et al., 1990, 1993; Gething and Sambrook, 
1992). Of these proteins, certain stress  proteins such  as 
glucose-regulated  protein 78 (GRP781 or Ig heavy chain- 
binding protein [BiP]) and GRP94 are thought to facilitate 
translocation into the ER and then to assist in folding, oli- 
gomeric assembly and sorting in the ER (Kozutsumi et al., 
1988; Melnick et al., 1992). The folding enzymes, which in- 
1. Abbreviations used in this paper: ARF, ADP ribosylation factor; BiP, Ig 
heavy chain binding protein; CEF, chick embryo fibroblast; DSP, dithiobis 
(succinimidylpropionate); endo  H,  endoglycosidase  H;  GRP,  glucose- 
regulated protein; HSP, heat shock protein; KDEL, Lys-Asp-Glu-Leu se- 
quence;  PDI, protein disulfide  isomerase; RDEL, Arg-Asp-Glu-Leu se- 
quence. 
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isomerase  (PDI),  are  involved  in  the  posttranslational 
modification of proteins such as procollagen (Chessler and 
Byers, 1993; Chessler et al., 1993). The sequential forma- 
tion of disulfide bonds in the ER is required for normal 
folding and for subsequent transport to the Golgi appara- 
tus  and beyond (Koivu and Myllyla, 1987; Hurtley and 
Helenius, 1989). These soluble ER-resident proteins have 
the sequence Lys-Asp-Glu-Leu (KDEL) at their carboxy 
terminus, which acts as an ER-retention signal (Munro and 
Pelham, 1987). Similarly, some ER-resident type I trans- 
membrane proteins contain an ER-targeting motif consist- 
ing of two lysine residues at the carboxy terminus (Nilsson 
et al., 1989; Jackson et al., 1993). 
Heat shock protein 47 (HSP47) is a 47-kD heat-induc- 
ible stress protein found in collagen-producing cells, where 
it functions as a collagen-binding glycoprotein (Nagata et 
al., 1986, 1988; Saga et al., 1987; Nakai et al., 1992). HSP47 
has an Arg-Asp-Glu-Leu sequence (RDEL) at the COOH 
terminus, and it has been observed to localize to the ER 
(Saga et al., 1987; Nakai et al., 1990; Hirayoshi et al., 1991; 
Takechi  et  al.,  1992).  We  previously demonstrated that 
HSP47 was coprecipitated with newly synthesized procol- 
lagen chain(s) using a chemical cross-linker, and that HSP47 
was  stably  associated  with  those  procollagen  chain(s) 
when the cells were treated with a, a'-dipyridyl, an iron- 
chelating agent that blocks prolyl and lysyl hydroxylation, 
thus preventing the stable triple-helix formation of procol- 
lagen (Nakai et al., 1992). HSP47 was therefore postulated 
to be a molecular chaperone-like protein resident in the ER. 
In  addition  to  this  functional  relationship  between 
HSP47 and procollagen, the expression of HSP47 is always 
closely correlated with the expression of various types of 
collagen. The synthesis of both HSP47 and type I collagen 
are decreased after the malignant transformation of fibro- 
blasts (Nagata et al., 1988; Nakai et al., 1990). Conversely, 
the  synthesis of both  HSP47  and  type  IV  collagen  are 
markedly increased during the differentiation of the mouse 
teratocarcinoma cell line F9 (Kurkinen et al., 1984; Take- 
chi et al., 1992).  We recently reported that both HSP47 
and type I and III collagens are clearly induced during the 
progression of rat liver fibrosis caused by the administra- 
tion of carbon tetrachloride (Masuda et al., 1994). These 
observations suggest that HSP47  might be  important in 
the synthesis, processing, and secretion of collagen in vari- 
ous types of cells. Recent studies have shown that the re- 
ceptors for the  KDEL motif are  localized to the  Golgi 
membrane, and they mediate intracellular transport from 
the  Golgi  apparatus  to  the  ER  (Semenza  et  al.,  1990; 
Lewis  and  Pelham,  1990, 1992; Tang  et  al.,  1993).  Al- 
though there are many reports dealing with the function of 
ER-resident chaperone proteins, and the sequential inter- 
action of these chaperone proteins with unfolded substrate 
proteins in the ER was recently reported (Hammond and 
Helenius, 1994a; Melnick et al.,  1994), to our knowledge, 
there are few reports that clearly show where these chap- 
erones associate with and dissociate from their substrates. 
In  this  report,  we  have  analyzed  the  specific  location 
where  HSP47  associates  with  and  dissociates  from  the 
newly synthesized procollagen chains, by coprecipitation 
and pulse-label/chase experiments using a cross-linker, as 
well as by confocal microscopic observation. 
Materials and Methods 
Chemicals and Reagents 
The chemical cross-linker dithiobis  (succinimidylpropionate) (DSP) was 
purchased from Pierce  Chemical Co.  (Rockford,  IL).  Chromatographi- 
cally purified bacterial collagenase (form III) and recombinant endogly- 
cosidase H  (endo H) were obtained from Advance Biofaetures Co. (Lyn- 
brook, N¥)  and Boehringer Mannheim GmbH (Mannheim, Germany), 
respectively. Monensin sodium salt, brefeldin  A,  L-ascorbic acid phos- 
phate magnesium salt, and bafilomycin A1 were purchased from Wako 
Junyaku  (Osaka,  Japan).  ~,  ct'-dipyridyl  was  obtained  from  Nacalai 
Tesque (Kyoto, Japan).  Rabbit  antiserum raised against rat type  I  col- 
lagen was obtained from LSL Co. Ltd. (Tokyo, Japan). Rabbit polyclonal 
and rat monoclonal (11D10)  IgGs against chick HSP47 had been made 
previously (Saga et al., 1987; Nakai et al., 1992), and were used after affin- 
ity purification on chick HSP47-coupled Sepharose 4B column. Rabbit se- 
rum raised against the 15  amino acid residues at  the NH2 terminus of 
mouse HSP47 was also made, which specifically recognized mouse but not 
chick HSP47.  EXPRE35S35S  and L-[2,3-3H]proline were purchased from 
New England Nuclear (Boston, MA). The anti-Gotgi 58K protein mAb 
(Bloom and Braehear, 1989; Donaldson et al., 1990; Ktistakis et al., 1991) 
for staining the Golgi apparatus and trypsin were purchased from Sigma 
Chemical Co. (St. Louis, MO).  Rabbit polyclonal IgG against PDI and 
mouse monoclonal IgG against tx-mannosidase II were kind gifts from Dr. 
T. ¥oshimori (Kansai Medical University, Osaka, Japan) and Dr. G. War- 
ren  (Imperial  Cancer Research Fund, London, U.K.), respectively. All 
other reagents were purchased from Wako Junyaku and Nacalai Tesque. 
Cell Culture and Metabolic Labeling 
Chick embryo fibroblasts (CEFs) were maintained in Vogt's GM medium, 
and cell populations were passed with a 0.25% trypsin-1 mM EDTA solu- 
tion. The experiments were conducted between passages three and eight. 
Briefly 6 ×  105 cells were plated onto a 35-mm plastic dish, and were incu- 
bated at 37°C for 16-24 h in 5% CO2. The subconfluent cultures were then 
rinsed with methionine-free medium or proline-free  medium, preincu- 
bated in the same medium for 30 min, then labeled with 0.2 mCi/ml of 
[35S]methionine or 0.1  mCi/mi of L-[2, 3-3H]proline in the presence of 
2-2.5% dialyzed FCS for the indicated periods. 
Cross-linking and Immunoprecipitation 
Detailed protocols have been previously described (Nakai  et al., 1992). 
Briefly, cultured CEFs were rinsed with Ca  z+- and Mg  2+-free PBS and in- 
cubated with 200 Ixl of trypsin (0.025%)-EDTA (1 mM) at 37°C for 3 min. 
Then 800 Ixl of ice-cold medium containing 10% FCS to block trypsin ac- 
tivity was added to the trypsin-EDTA. After rinsing, the cell suspension 
was incubated with 2  mM DSP  (stored at  a  concentration of 0.1  M  in 
DMSO) on ice for 30 min, rinsed with 2 mM glycine in PBS to block DSP 
activity, rinsed with PBS again, and then lysed with a lysis buffer (50 mM 
Tris-HC1, pH 8.0, 0.15 M NaC1, 1% NP-40, 5 mM EDTA, 1 mM PMSF, 1 
mM N-ethylmaleimide, 1 Ixg/ml leupeptin, and 1 /~g/ml pepstatin) con- 
taining 0.5 mg/ml gelatin on ice for 15 rain. The excess gelatin served to 
prevent the binding of procollagen to HSP47 in the cell extract after cell 
lysis by competing with the endogenous procollagen. After centrifugation 
at  12,000  g  for  15 rain, the supernatant was divided into two equal ali- 
quots.  One aliquot was immunoprecipitated with the rabbit  polyclonal 
IgG against HSP47, and the other half was immunoprecipitated with the 
rabbit  antiserum raised  against  rat  type  I  collagen,  as  previously de- 
scribed. The samples were resuspended in Laemmli's sample buffer con- 
taining DTT, boiled for 5 rain, and analyzed by SDS-PAGE as previously 
described (Nakai et al., 1990,  1992).  The gels were dried and exposed on 
Fuji HR-H film (Fuji Photo Film Co., Ltd., Tokyo, Japan) after treatment 
with 1 M sodium salieylate. 
Confocal Scanning Laser Microscopy 
CEFs were cultured on coverslips for ~12 h in the presence or absence of 
5 txg/ml ascorbate. The cells were then treated with or without several in- 
hibitors for the secretory pathway, and then fixed with 4% paraformalde- 
hyde in PBS for 15 rain at room temperature. After permeabilization with 
either 0.2% Triton X-100 in PBS or with 0.1% Triton X-100 plus 0.05% 
SDS in PBS for 4 min, the coverslips were rinsed and then blocked with 
10% nonimmune goat serum and 2.5% skim milk (Yukijilushi Milk Co., 
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with a mixture of the primary antibodies: (30 ixg/ml rat anti-HSP47 mono- 
clonal IgG (llD10)  and 1:200 diluted rabbit antiserum raised against rat 
type I collagen (LSL Co. Ltd.)). The primary incubation was carried out in 
PBS containing 10% nonimmune goat serum and 2.5% skim milk. Goat 
anti-rat IgG coupled to FITC and rhodamine-conjugated goat anti-rabbit 
IgG were used as the secondary antibodies at a dilution of 1:200. The cov- 
erslips were mounted in a  drop of Slow Fade  TM (Molecular Probes, Inc., 
Eugene, OR) to reduce photobleaching. All the specimens were observed 
using a  laser  scanning confocal  apparatus  (MRC-600;  Bio-Rad  Micro- 
science Division, Herts, U.K.), and photographed with Fujichrome 100D 
film and Kodak Ektachrome 100 Plus film (Eastman Kodak Co., Roches- 
ter, NY). 
Trypsin and Collagenase Treatments 
The immunocomplexes precipitated  with protein  A-agarose (20  Ixl bed 
vol) were incubated with 20 ~g/ml trypsin at 37°C for 4 min or with 33 o.l 
of collagenase buffer (20 U/ml collagenase, 50 mM Tris-HC1, pH 7.5,  2 
mM PMSF, 10 mM CaCl2) at 37°C for 30 min. These samples were then 
boiled for 5 min in Laemmli's sample buffer and DTI', and then applied to 
an SDS-polyacrylamide gel for electrophoresis. 
Construction  of an Expression Vector 
and Transfection 
The truncated HSP47 lacking the RDEL sequence at the COOH terminus 
was constructed using a mouse HSP47 cDNA (MH47) by PCR (Saiki et 
al., 1988) using oligonucleotides A  (5'-CCGGATCCATGGTGGACAA- 
CCGTGGCTTC-3') and B  (5'-CCGGATCCCTACATCTTGTCTCCCT- 
TGGG-3') as primers. Primer B contains a complementary sequence for 
the mouse HSP47 cDNA (Takechi et al., 1992)  between positions 1478 
and 1495, and a stop codon, followed by a BamHl site at the 5' end. The 
product (0.6 kb) from the PCR was cut with BamHI and subcloned into a 
pUC19 vector predigested with the same enzymes. This product was con- 
firmed by sequencing, and then subcloned as a XhoI-EcoRI fragment into 
a  pMH47a  construct (Takechi  et  al.,  1992)  predigested with XhoI  and 
EcoRI. The RDEL-deleted MH47 was digested with EcoRI and HindlII, 
added to a BglII linker, and ligated into the BglIl site of the expression 
vector pcDEBA (Nakabeppu et al., 1993). This expression vector was des- 
ignated as MH47ARDEL and was transiently transfected into CEFs by 
the calcium phosphate method. The secretion of this mutant HSP47 was 
examined in an in vitro assay. 
Results 
Inhibition of Procollagen Secretion in the ER 
CEFs cultured in the presence or absence of 5 Ixg/ml ascor- 
bate phosphate ester for 12 h were labeled with [35S]me- 
thionine for 10 min and then cross-linked with DSP for 30 
min. The detergent-soluble proteins were immunoprecipi- 
tated with anti-HSP47 and anticollagen antibodies, as de- 
scribed in Materials and Methods. The secretion of procol- 
lagen into  the  culture medium was  delayed without the 
addition of a bovine embryo extract containing ascorbate, 
a  cofactor for prolyl-4-hydroxylase, prolyl-3-hydroxylase, 
and lysyl hydroxylase (Fig. 1 A, lanes 9-12). The addition 
of ascorbate phosphate ester, a longer-lived derivative of 
ascorbate,  induced  the  active  secretion  of procollagen, 
which was demonstrated by the disappearance of the pro- 
collagen band after 20-40 min of the chase period (Fig. 1 
A, lanes 13-16). The molecular sizes of procollagen bands 
without ascorbate were slightly different from those with 
ascorbate  because  of the  hydroxylation of proline  and 
lysine residues and the subsequent O-glycosylation (Fig. 1 
A, lane 9 vs lane 13). In the presence of ascorbate, the pro- 
collagen  that  was  coprecipitated with  HSP47  using  the 
anti-HSP47 antibody disappeared more rapidly than that 
in the absence of ascorbate (Fig. 1 A, lanes 5-8 vs lanes 1-4). 
Quantitative  examination more clearly showed the  pro- 
longed  binding  of HSP47  to  underhydroxylated procol- 
lagen during the chase periods (Fig. 1, B  and C). Procol- 
lagen ed(I) chain bound to HSP47 decreased much slower 
in the absence of ascorbate than in the presence of ascor- 
bate (Fig. 1 B). The HSP47-bound or(I) chain/total cd(I) 
chain of procollagen decreased rapidly in the presence of 
ascorbate, whereas  it decreased much slower in  the  ab- 
sence of ascorbate (Fig.  1 C). Fig.  1 C  suggests that the 
prolonged binding of procollagen to HSP47 in the absence 
of ascorbate is not merely caused by the large accumula- 
tion of procollagen in the ER. These results indicate that 
the  underhydroxylated procollagen  remained  bound  to 
HSP47 for a much longer period than normal procollagen. 
When the cell lysates were immunoprecipitated with the 
anticollagen antibody, HSP47 was not detected in the im- 
munocomplex (Fig. 1, lanes 9-16). This was partly caused 
by the poor labeling efficiency of HSP47 after pulse label- 
ing for a short period because the half life of HSP47 is very 
long  (>48  h;  Nakai  et al.,  1992).  Previously, we  clearly 
showed that the immunocomplexes precipitated with the 
anticollagen antibody contained detectable levels of HSP47 
by labeling the cells with [35S]methionine for longer peri- 
ods or by Western blot analysis using anti-HSP47 antibody 
(Nakai et al.,  1992).  Nevertheless, it should be noted that 
only a  small fraction of newly labeled  HSP47 bound to 
procollagen in the ER (Fig. 1, lanes 9-16), as reported for 
BiP (Hurtley et al.,  1989). Colocalization of procollagen 
with HSP47 was confirmed by confocal microscopic obser- 
vation  after  the  CEFs  were  double  stained  with  anti- 
HSP47  and  anticollagen  antibodies,  and  visualized with 
FITC-conjugated  and  rhodamine-conjugated  secondary 
antibodies,  respectively. Since  almost  all  of the  procol- 
lagen was secreted out of the cells in the presence of ascor- 
bate, only HSP47 was immunostained within the cells (Fig. 
2, D-F).  In  the absence of ascorbate, however, a  strong 
yellow staining was observed on the confocal micrograph, 
indicating  the  colocalization of HSP47  and  procollagen. 
This yellow staining, consisting of HSP47 plus procollagen, 
coincided with  the  HSP47  staining  pattern,  which  indi- 
cated that the HSP47 and procollagen complexes had ac- 
cumulated in the ER. 
In the absence of ascorbate, some portion of the procol- 
lagen was localized to a site distinct from the ER, possibly 
in the Golgi (Fig. 2, A-C, also see Fig. 7). In a previous pa- 
per, we showed that procollagen was inhibited from being 
secreted and remained bound to HSP47 for a much longer 
period when the CEFs were treated with tx, c~'-dipyridyl, 
an  iron-chelating agent  that  blocks prolyl and  lysyl hy- 
droxylation (Nakai et al.,  1992).  This inhibition was also 
shown to occur in the ER by confocal microscopic obser- 
vation (Fig. 2, G-/). These results indicated that procol- 
lagen was not dissociated from HSP47 when the secretion 
of procollagen was inhibited in the ER, either by ascorbate 
deprivation or by treatment with a, tx'-dipyridyl. Based on 
these results, we performed the following experiments in 
the presence of ascorbate phosphate ester to examine the 
secretion of procollagen under more normal conditions. 
Treatment of CEFs with Brefeldin A 
Brefeldin A is known to release coat proteins and ADP ri- 
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Figure  1.  Effects  of  ascor- 
bate on the secretion  of pro- 
collagen  and  the  interaction 
of procollagen  with  HSP47. 
CEFs  were  preincubated  in 
the presence or absence of 5 
vg/ml  ascorbate  phosphate 
for 12 h,  pulse  labeled with 
0.2  mCi/ml  [35S]methionine 
for 10 min,  and then chased 
in medium containing  excess 
cold methionine  for the indi- 
cated time periods.  The cells 
were  trypsinized,  incubated 
with  the  cross-linking  re- 
agent,  and  treated  with  the 
lysis buffer.  Immunoprecipi- 
tation was performed as de- 
scribed  in  Materials  and 
Methods.  (A) The immuno- 
complexes  precipitated  with 
anti-HSP47  antibody  (lanes 
1--8) or anti-type I  collagen 
antiserum (lanes  9-16) were 
applied  to an SDS-8% poly- 
acrylamide  gel,  electropho- 
resed,  and  exposed  on  Fuji 
HR-H film. The number on 
top of each lane indicates the 
duration of the chase period 
in  minutes.  (B)  Kinetics  of 
procollagen  coprecipitated 
with  HSP47 in the presence 
or  absence  of  ascorbate 
phosphate.  (C)  Kinetics  of 
the  HSP47-bound  procol- 
lagen/total  intracellular  pro- 
collagen ratio.  After the gels 
were exposed  on Fuji HR-H 
film,  the  relative  density  of 
the  bands  corresponding  to 
al(I)  procollagen  was  esti- 
mated  using  a  one-dimen- 
sional  image  analyzer  (The 
Discovery  Series,  Quantity 
One; PDI, Huntington, NY). 
The value of the relative den- 
sity before chase  was desig- 
nated  as  arbitrary one  unit. 
Open  circles,  al(I)  procol- 
lagen in the absence of ascor- 
bate phosphate; closed circles, 
al(I) procollagen in the pres- 
ence of ascorbate phosphate. 
bosylation factor (ARF) from the Golgi stack, and thus in- 
hibits the transport of secretory proteins from the ER to 
the Golgi (Lippincott-Schwartz et al., 1989, 1990; Klausner 
et  al.,  1992;  Duden  et  al.,  1994).  CEFs  were  pretreated 
with  or  without  2  i~g/ml  brefeldin  A  for 30  min,  pulse- 
labeled with [35S]methionine for 10 min, and then chased 
for the  indicated  periods  in  the  presence  of excess cold 
methionine.  The  cells  were  then  treated  with  a  cross- 
linker, and the cell extract was immunoprecipitated with 
anti-HSP47  and  anticollagen  antibodies  as  described  in 
Materials and Methods. Although almost all of the pulse- 
labeled procollagen had been secreted from the cells after 
40 min in the absence of brefeldin A  (Fig. 3 A, lanes 9-12), 
the secretion of procollagen was completely inhibited  by 
the presence of brefeldin A  (lanes 13-16). The amount of 
procollagen and collagen chains secreted into the culture 
medium was examined directly by SDS-PAGE, and these 
results also showed the complete inhibition of all protein 
secretion into the medium (Fig. 3 B). 
Immunoprecipitation analysis using the anti-HSP47 an- 
tibody  after cross-linking  revealed  that  the  procollagen, 
which could not be secreted in the presence of brefeldin A, 
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and procollagen in cells treated 
with ascorbate and ct, a'-dipy- 
ridyl. CEFs were preincubated 
in  the  presence  (D-/)  or  ab- 
sence (A-C) of 5 ~g/ml ascor- 
bate  phosphate for 12  h,  and 
then treated with 0.3 mM a, et'- 
dipyridyl  for 2  h  (G-/).  The 
cells  were  fixed,  permeabi- 
lized, and double stained  with 
the  rat  anti-HSP47  mAb 
(llD10)  and  the  rabbit  anti- 
type I collagen  antiserum.  Vi- 
sualization  was  performed 
with  FITC-conjugated  goat 
anti-rat  IgG for  HSP47,  and 
with  rhodamine-conjugated 
goat anti-rabbit IgG for pro- 
collagen.  Images  were  ob- 
tained  with  a  scanning  laser 
confocal  microscope  sepa- 
rately for HSP47  (A,  D,  and 
G) or type I procollagen  (B, E, 
and  H),  and  by  overlapping 
them (C, F, and/). In the dou- 
ble  staining  with  both  FITC 
and  rhodamine  images,  the 
yellow color indicates the over- 
lap of the two fluorescent anti- 
bodies (C, F, and I). 
remained bound to HSP47 for up to 60 min, whereas most 
of the  procollagen had  dissociated  from HSP47  after 20 
min under normal conditions (Fig. 3 A, lanes 1-4 and 5-9). 
Cells  were  double-stained  with  anti-HSP47  and  anticol- 
lagen  antibodies  and  observed  by  confocal  microscopy. 
Anticollagen  antibody  stained  many small vesicles  after 
treatment with brefeldin A  (Fig. 4 B). When green (HSP47) 
and  red  (collagen)  staining  were  superimposed,  it  was 
clearly shown that HSP47 and procollagen colocalized in 
these small vesicles (Fig. 4  C). Anti-HSP47 antibody also 
strongly  stained  the  ER  structure  (Fig.  4  A),  indicating 
that most of the  HSP47 remained in  the ER,  even after 
treatment with brefeldin A. This is consistent with the ob- 
servation that  only a  small fraction of HSP47  bound  to 
procollagen in the ER, as mentioned above (Fig. 1). Stain- 
ing with anti-PDI antibody indicates that the appearance 
of small vesicles by treatment with brefeldin A  did not re- 
sult from the destruction of the ER structure because this 
treatment did not affect the reticular meshwork structure 
of the  ER  (Fig.  5  B).  Besides  the  ER  staining  pattern, 
staining with anti-PDI antibody also showed the colocal- 
ization of PDI with HSP47  in  the  small vesicles (yellow 
spots).  To examine whether  these  small vesicles are  de- 
rived from the  dispersion  of the  Golgi stack, we stained 
the cells with anti-p58  antibody to stain the  Golgi struc- 
ture. This anti-p58 antibody recognizes the Golgi protein 
known as "58K protein," which binds directly to microtu- 
bules  and  is  postulated  to  be  involved in  anchoring  the 
Golgi apparatus to microtubules in vivo (Bloom and Brash- 
ear,  1989;  Ktistakis  et  al.,  1991;  Saraste  and  Svensson, 
1991).  It should be noted this p58 protein in the  Golgi is 
not the same one as an intermediate compartment marker 
protein, hence the name "p58." Anti-p58 antibody clearly 
stained  the  Golgi structure  in  CEFs  in  the  presence  of 
ascorbate (Fig. 5  C). However, no staining was observed 
with  this  antibody in  the  cells  treated  with  brefeldin  A 
(Fig. 5 D). Although it is noteworthy that the loss of p58 
staining in brefeldin A-treated cells possibly resulted from 
the membrane uncoating, these results seem to be consis- 
tent with the previous report that brefeldin A  treatment 
causes a  disappearance of the Golgi structure (Lippincott- 
Schwartz et al., 1989; Ktistakis et al., 1991).  These observa- 
tions suggest that these small vesicles observed after treat- 
ment with brefeldin A  are distinct  from the ER  and the 
Golgi. 
When brefeldin A was removed from the medium, these 
small vesicles disappeared after 60 min, and the anti-HSP47 
antibody again revealed an ER staining pattern, whereas 
the staining with the anticollagen antibody was located in 
the Golgi and then disappeared (data not shown).  When 
the cells were treated with c~, a'-dipyridyl and then with 
brefeldin A, the staining patterns of the cells stained with 
anti-HSP47 and anticollagen antibodies were indistinguish- 
able  from  cells  treated  with  or,  a'-dipyridyl  alone,  thus 
showing the ER pattern  (Fig.  5 A). This result indicated 
that these small vesicles did not appear when the secretion 
of procoUagen from the ER was inhibited by a, a'-dipy- 
ridyl treatment, and that the appearance of these vesicles 
was not due to an artifact caused by brefeldin A treatment. 
These results also imply that the small vesicles might rep- 
resent an intermediate compartment between the ER and 
Golgi. 
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on the interaction  of procollagen 
with HSP47. The cells were cul- 
tured  in  medium  containing  5 
txg/ml ascorbate  phosphate  for 
12  h,  and  were  then  preincu- 
bated in the presence or absence 
of 2  p~g/ml brefeldin  A  for 30 
min.  The  cells  were  pulse- 
labeled with 0.2 mCi/ml [3SS]me- 
thionine  for  10  min,  and  were 
chased  in  medium  containing 
excess  cold  methionine.  Cross- 
linking and immunoprecipitation 
were performed as described in 
Materials  and Methods.  (A) Im- 
munocomplexes  precipitated 
with  the  anti-HSP47  antibody 
(lanes  1--8) or  the  anti-type  I 
collagen  antibody  (lanes  9-16) 
were applied to a SDS-8% poly- 
acrylamide  gel,  electropho- 
resed, and exposed on Fuji HR-H 
film.  (B)  Culture  medium was 
collected  and then analyzed  by 
SDS-PAGE  after  various  time 
periods of chase. The number on 
top  of  each  lane  indicates  the 
duration of the chase period in 
minutes. 
When cells were treated at 15°C  for 30 min, the secre- 
tion of procollagen was inhibited, and the procollagen was 
shown to be bound to HSP47, as previously reported (Na- 
kai et al., 1992).  The treatment of the cells at this tempera- 
ture is known to cause the inhibition of transport between 
the ER  and  Golgi, presumably at the  intermediate com- 
partment (Tartakoff, 1983; Schweizer et al., 1988, 1990; Sa- 
raste  and  Svensson,  1991).  We  next  examined  whether 
these small vesicles containing both procollagen and HSP47 
could be observed when the cells were treated at low tem- 
peratures.  Since protein synthesis is inhibited  at this low 
temperature and the  localization of procollagen was not 
visualized in the presence of ascorbate because of active 
secretion, we first incubated the  CEFs in the  absence of 
ascorbate for  12 h  to allow procollagen  accumulation in 
the ER, and then incubated the cells at 15°C in the pres- 
ence of ascorbate. As shown in Fig. 4 F, inhibition of pro- 
collagen secretion was observed to occur in small vesicles 
that were similar to those observed after treatment of the 
cells with brefeldin A  (Fig. 4  C). These vesicles that had 
accumulated  at  15°C  contained  both HSP47  and  procol- 
lagen (yellow staining). Staining with anti-HSP47 antibody 
again revealed that  a  considerable  amount of HSP47 re- 
mained in the ER (Fig. 4  D). This result again indicated 
that  the  procollagen was not  dissociated  from HSP47  in 
the intermediate compartment. 
Treatment of CEFs with Monensin and Bafilomycin A1 
Monensin is an ionophore for Na  +, K +, and protons, and it 
is known to inhibit intracellular transport within the Golgi 
complex, preferentially between  the cis- or medial-Golgi 
and  trans-Golgi  compartment  (Tartakoff,  1983;  Rosa  et 
al.,  1992).  CEFs  were  incubated  with  or  without  5  ixM 
monensin for 60 min, pulse-labeled with [35S]methionine, 
and  then  chased  for various periods.  In the  presence of 
monensin, the secretion of procollagen was inhibited  for 
up to 60 rain, which was similar to the treatment with a, 
t~'-dipyridyl or brefeldin A  (Fig. 6 A, lanes 13-16). How- 
ever, these accumulated procollagens were not coprecipi- 
tated with HSP47 after the chase period, when the cell ex- 
tract was immunoprecipitated with the anti-HSP47 antibody 
(Fig.  6  A,  lanes  5-8).  Procollagen  bound  to  HSP47  de- 
creased rapidly in monensin-treated cells during the chase 
period, as was seen in the nontreated cells (Fig. 6 A, lanes 
1--4). Therefore, while the secretion of procollagen was in- 
hibited by treatment with monensin, the procollagen dis- 
sociated  normally from HSP47,  even in  the  presence  of 
monensin. 
Similar results were obtained when the secretion was in- 
hibited  by  treatment  with  bafilomycin  A1,  which  is  a 
strong inhibitor  of the  vesicular-type H+-ATPase and  is 
known  to  inhibit  secretion  at  the  trans-Golgi  network 
(Umata et al., 1990; Henomatsu et al., 1993).  After treat- 
ment of the CEFs with 1 I~M bafilomycin A1 for 60 min, 
the cells were chased for various time periods, and the dis- 
sociation  of procollagen  from  HSP47  was  similarly  ob- 
served  in  the  presence  of  monensin  (data  not  shown). 
There is a  possibility, however, that the  [35S]methionine- 
labeled procollagen was simply displaced from HSP47 by 
unlabeled, newly synthesized procoUagen, which could result 
in  the  apparent dissociation  of procollagen from HSP47 
during the chase period. This possibility was excluded by 
treating the cells with cycloheximide after pulse labeling to 
The Journal of Cell Biology, Volume 133, 1996  474 Figure 4.  Effects of brefeldin A and low temperature on the localization of HSP47 and procollagen.  CEFs were cultured in medium with 
(A-C) or without (D-F) 5 p,g/ml ascorbate phosphate for 12 h. The cells were then treated with 2 p~g/ml  brefeldin A for 30 min (A-C), 
or they were incubated for 2 h at 15°C (C). The ceils were fixed, permeabilized,  double stained  with the combination of the rat anti- 
HSP47 mAb (llD10) and the rabbit anti-type I collagen serum, followed by incubation with the FITC-conjugated goat anti-rat IgG and 
the rhodamine-conjugated goat anti-rabbit IgG, respectively,  as the secondary antibodies.  Images were obtained with a scanning laser 
confocal microscope separately for HSP47 (A and D) or type I procollagen  (B and E), and by overlapping them (C and F). In the double 
staining with both FITC and rhodamine images, the yellow color indicates the overlap of the two fluorescent  antibodies  (C and F). 
prevent procollagen synthesis. Even in the presence of cy- 
cloheximide, the dissociation of procollagen from HSP47 
was simililarly observed after the treatment of the CEFs 
with monensin or bafilomycin A1 (data not shown). 
This dissociation of procollagen from HSP47 in the pres- 
ence  of monensin  or  bafilomycin A1  was  demonstrated 
more directly by confocal microscopic observation. After 
60  min  of  monensin  treatment,  the  CEFs  were  immu- 
nostained  with  anti-HSP47  and  anticollagen  antibodies. 
As  shown  in  Fig.  7  A,  procollagen  accumulated  within 
these cells. The site of procollagen accumulation, however, 
was clearly distinct from the localization of HSP47, result- 
ing in the red staining characteristic of collagen molecules. 
Some  yellow staining  in  the  ER  demonstrated  that  the 
newly synthesized  procollagen was bound  to  HSP47  be- 
cause  protein  synthesis  was  not  blocked  in  this  experi- 
ment.  The  site  where  the  procollagen  had  accumulated 
should be the Golgi compartment, because of the reported 
inhibitory mechanism by monensin (Tartakoff, 1983; Rosa 
et al., 1992). To identify this site more clearly, we tried to 
stain the CEFs with anti-mannosidase II antibody. Unfor- 
tunately, however, this  antibody did not cross-react with 
the chick protein.  The site of procollagen accumulation 
in the monensin-treated cells was next examined by stain- 
ing the cells with anti-p58 antibody (Golgi marker). Immu- 
nostaining demonstrated the colocalization of the procol- 
lagen and p58 protein in these cells (Fig. 7  C). Although 
the  secretion  of  procollagen  was  similarly  inhibited  by 
treatment  of the  cells  with  bafilomycin A1,  it  was clear 
that  the  procollagen  no  longer  colocalized  with  HSP47 
(Fig. 7 B). 
These results indicated that the procollagen had already 
dissociated from HSP47 in the cis- or medial-Oolgi com- 
partment. When the cells were treated with monensin and 
then the cell lysates were treated with endo H, fibronectin 
bands which were identified with an antifibronectin  anti- 
body became endo H  sensitive (data not shown). This sug- 
gests that monensin inhibited the secretion at the cis-Golgi 
compartment because fibronectin should be endo H  resis- 
tant if it enters the medial-Golgi compartment (Kornfeld 
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HSP47, procoIlagen, PDI, and 
p58  after  treatment  with 
brefeldin A combined with or 
without a, a'-dipyridyl.  CEFs 
were cultured  in the presence 
of  5  vLg/ml ascorbate  phos- 
phate  for 12 h.  (A)  The  cells 
were  then  preincubated  with 
0.3 mM a, a'-dipyridyl for 1 h 
followed by treatment  with 0.3 
mM cx, a'-dipyridyl  plus 2 v.g/ 
ml brefeldin A for 30 min. The 
cells were treated  with (B and 
D)  or  without  (C)  2  Ixg/ml 
brefeldin  A  for 30 min. Cells 
were fixed, double stained and 
visualized by scanning confo- 
cal microscopy as described in 
Fig.  4.  Antibodies  used  for 
double staining were as follows 
(fluoresceins used to visualize 
the  first  antibody  are  also 
shown in parentheses): (A) rat 
anti-HSP47 mAb (F1TC) and 
rabbit  anti-type I collagen se- 
rum  (rhodamine),  (B)  rat 
anti-HSP47 mAb (FITC)  and 
rabbit  anti-PDI  antibody 
(rhodamine),  (C)  rabbit  anti- 
HSP47 antiserum  (Texas red) 
and  mouse  anti-p58  mAb 
(FITC), and (D) rabbit anti-type I collagen serum (Texas red) and mouse anti-p58 mAb (FITC). Overlapped images obtained by scan- 
ning eonfocal microscopy were shown for each set of the double staining. 
and Kornfeld, 1985). Thus, from all the available data de- 
scribed above, the dissociation of procoUagen from HSP47 
was concluded to occur in the cis-Golgi network. 
Endo H Sensitivity  of HSP47 before and after Deletion 
of the RDEL Sequence at the COOH Terminus 
In the above experiments, we noticed that HSP47 was still 
endo H  sensitive  even  after  treatment  of the  cells  with 
brefeldin A  (data not shown). It has been reported that 
ER-resident proteins such as GRP94 acquire resistance to 
treatment with endo H  after the cells  have been treated 
with  brefeldin  A  for  3-6  h  (Lippincott-Schwartz et  al., 
1989,  1990).  This  results  from a  redistribution  of Golgi 
proteins, including glycosidation enzymes into the ER. To 
confirm whether HSP47  still  remained  endo H  sensitive 
even after it entered the medial- or trans-Golgi cisternae, 
as  well  as  to  confirm  that  the  RDEL  sequence  at  the 
COOH terminus actually acts as an ER-retention signal, we 
prepared  an  RDEL  sequence-deleted  cDNA  construct 
from mouse HPS47 cDNA (Takechi et al., 1992). We then 
transfected it into the CEFs and examined the endo H sen- 
sitivity of HSP47 that was secreted into the medium. We 
used the mouse HSP47 for the deletion of the RDEL se- 
quence because we can discriminate the transfected mouse 
HSP47 from the endogenous chick HSP47 by specific anti- 
bodies. The RDEL-deleted mouse HSP47 (MH47ARDEL) 
was transfected into the CEFs by the calcium phosphate 
method, and was then immunoprecipitated with anti-chick 
and anti-mouse HSP47 antibodies 3 d later. As shown in 
Fig. 8 A, the amount of transfected RDEL-deleted HSP47 
decreased during the chase period, but did not decrease in 
the presence of monensin. This antibody did not recognize 
the endogenous chick HSP47 (Fig. 8 A, lanes 1 and 2), and the 
amount of endogenous HSP47 did not change during the 
chase period (data not shown). RDEL-deleted HSP47 was 
secreted  into  the  medium  in  the  absence  of monensin, 
whereas the secretion was greatly reduced in the presence 
of monensin (Fig. 8 B). The secreted HSP47 was examined 
for endo  H  sensitivity  after  being precipitated  with  the 
anti-mouse HSP47 antibody, and Fig.  8  C clearly shows 
that the secreted HSP47 again failed to acquire resistance 
to endo H. The RDEL-deleted HSP47, which accumulated 
in the cell after monensin treatment, was also shown to be 
endo H  sensitive  (data not shown). This inability to  ac- 
quire endo H resistance suggests that the glycosylation en- 
zymes in the Golgi complex could not gain access to HSP47. 
The above results also revealed that the RDEL sequence 
at the COOH terminus of HSP47 acts as an ER-retention 
signal,  as the KDEL sequence does (Munro and Pelham, 
1987). 
HSP47 Can Bind to Both the al(I) Single Chain and 
Mature Procollagen 
Since  molecular  chaperones  like  HSP70  and  the  GroE 
complex are known to bind only to the immature form of 
the  polypeptide and become dissociated  from their  sub- 
strates once the proteins adopt their mature form, it was of 
interest to examine whether HSP47 can bind to the imma- 
The Journal of Cell Biology, Volume 133, 1996  476 Figure 6.  Effects of monensin on interaction of procollagen  with HSP47. CEFs were cultured  in medium containing  5 Ixg/ml  ascorbate 
phosphate for 12 h, and were preincubated in the presence or absence of 5 poM monensin. The cells were pulse-labeled  with 0.2 mCi/ml 
[35S]methionine for 10 min, and were then chased in medium containing excess cold methionine.  The cross-linking and immunoprecipi- 
tation experiments were performed as described  in Materials  and Methods.  (A) Immunocomplexes precipitated with the anti-HSP47 
antibody (lanes 1-8) or the anti-type I collagen antibody (lanes 9-16) were applied to an SDS-8% polyacrylamide gel, electrophoresed, 
and exposed on Fuji HR-H film. (B) Medium was collected and analyzed by SDS-PAGE after various time periods of chase. The num- 
ber on top of each lane indicates the duration of the chase period in minutes. 
ture form and/or to the mature form of procollagen mole- 
cules, or even to the al(I) polypeptide chain. 
First,  the  binding  of  HSP47  to  the  immature  single 
polypeptide form of type I  procollagen was examined in 
vivo by immunoprecipitation after a  short pulse labeling. 
Immediately after  the  CEFs  were  labeled  with  [35S]me- 
thionine for 10 min, the cell lysates were immunoprecipi- 
tated with anti-HSP47 and anticollagen antibodies, either 
with  or without  cross-linking with  DSP.  These  immuno- 
precipitates were then electrophoresed in the presence or 
absence of dithiothreitol (DTT). 
Fig. 9 A shows that the procollagen precipitated with the 
anticollagen antibody consisted of mainly two bands, up- 
per and lower bands that were both collagenase sensitive 
(Fig. 9 A, lanes 3 and 4). Type I collagen is known to form 
a triple helix at the COOH terminus by forming intermo- 
lecular disulfide bonds between two al(I)  and one c~2(I) 
polypeptide chains  (Rosenbloom et al.,  1976;  Koivu and 
Myllyla, 1987; Chessler et al., 1993a). The upper band, un- 
der nonreduced conditions, is therefore thought to be a tri- 
mer form of procollagen because a trimer form of C-pro- 
peptide,  (C-propeptide)3,  appeared  after  treatment  with 
collagenase in the absence of DTT (lane 4), and the lower 
band is thought to be a monomer form of procollagen be- 
fore it forms triple helices. This upper band disappeared in 
the presence of DTI', and two bands, pro-eO(I) and pro- 
a2(I)  chains  of procollagen,  appeared instead  (Fig.  9  B, 
lane  3),  which  again  suggests  that  the  high  molecular 
weight  band  is  the  trimer  form  of  procollagen.  Anti- 
HSP47  antibody precipitated both the  trimer and mono- 
mer forms of procollagen in addition to HSP47 itself under 
nonreduced  conditions  (Fig.  9  A,  lane  1).  Thus,  it  was 
clearly  shown  that  HSP47  could  bind  to  the  monomer 
forms of procollagen as well as to the trimer form. 
To examine whether  HSP47  could bind to the  mature 
triple-helix  form of procollagen  within  the  cells,  we  ex- 
ploited the resistance of the triple-helical region of procol- 
lagen against proteinase digestion. Procollagen consists of 
two  nonhelical  regions  at  the  NH2  and  COOH  termini, 
plus a helical domain that is resistant to trypsin digestion. 
Since  only  a  small  number  of methionine  residues  are 
found  in  the  helical region of type I  collagen,  the  CEFs 
were labeled with  [3H]proline instead of [35S]methionine 
in this experiment. After preincubation in proline-free me- 
dium  in  the  presence  or  absence  of  brefeldin  A  or  e~, 
a'-dipyridyl, the cells were pulse-labeled with [3H]proline 
Satoh et al. Interaction of liSP47 with Procollagen  477 Figure Z  Effects of monensin and bafilomycin A1 on the localization of HSP47 and procollagen. CEFs were cultured in medium con- 
taining 5 ixg/ml ascorbate phosphate for 12 h, and then treated with either 5 IxM monensin for 60 min (A and C) or with 1 txM bafilomy- 
cin A1 for 60 rain (B). (A and B) The cells were fixed, permeabilized, double stained with the combination of the rat anti-HSP47 mAb 
(llD10)  and  the  rabbit  anti-type  I collagen antiserum,  followed by incubation  with the FITC-conjugated goat anti-rat  IgG and  the 
rhodamine-conjugated goat anti-rabbit IgG, respectively, as the secondary antibodies. (C) Cells were also stained with the combination 
of the rabbit anti-type I collagen serum and the mouse anti-p58 mAb (C), followed by incubation with the Texas red-conjugated goat 
anti-rabbit IgG and the F1TC-conjugated goat anti-rat IgG, respectively, as the secondary antibodies. Images obtained by scanning la- 
ser confocal microscopy were visualized as described in the legend of Fig. 4. 
for 30 min and then chased for various time periods in the 
presence of excess proline. Because HSP47 contains such a 
small number of proline residues, HSP47 could not be de- 
tected,  even after immunoprecipitation  with  anti-HSP47. 
Procollagen  was  precipitated  with  the  anticollagen  anti- 
body (Fig. 10 B, lanes 7-12), and the procollagen that was 
bound  to HSP47 was coprecipitated with the  anti-HSP47 
antibody (Fig.  10 A, lanes 7-12). When the immunecom- 
plex precipitated with the anticollagen antibody was treated 
with  trypsin,  the  procollagen  bands  in  the  cells  treated 
with (x, cd-dipyridyl were completely digested  (Fig.  10 B, 
lanes 1-3), whereas the procollagen in brefeldin A-treated 
cells was resistant to trypsin digestion (Fig. 10 B, lanes 4~5). 
HSP47-bound procollagens were also treated with tryp- 
sin. HSP47-bound procollagen that had been treated with 
c~,  c(-dipyridyl  was  completely  digested,  whereas  the 
HSP47-bound procollagen in cells pretreated with brefel- 
din A was trypsin resistant (Fig. 10 A, lanes 1~5). These re- 
sults indicated that HSP47 can bind to the triple-helix form 
of  procollagen  (Fig.  10),  as  well  as  to  the  single  cd(I) 
polypeptide chain form of procollagen (Fig. 9). 
Discussion 
HSP47 Binding and Dissociation  of Procollagen 
HSP47,  a  heat  shock-inducible  glycoprotein  localized  in 
the  ER,  was found  to  bind  to  both collagen  and  gelatin 
(Nagata et al.,  1986; Saga et al., 1987).  HSP47 was previ- 
ously reported to bind transiently to procollagen in the ER 
using in vivo cross-linking and immunoprecipitation tech- 
niques with anti-HSP47 and anticollagen antibodies, com- 
bined  with  pulse-label  and  chase  methods  (Nakai et  al., 
1992). In normal cells, the dissociation of HSP47 from pro- 
collagen precedes the secretion of procollagen out of the 
cells.  However, HSP47 remains bound to procollagen for 
much  longer  periods  of  time  when  the  cells  are  heat 
shocked or treated with c~, cd-dipyridyl. Thus,  HSP47 can 
be presumed to be a molecular chaperone-like protein spe- 
cific for collagen. Similarly, the underhydroxylated procol- 
lagen  was  retained  to  be  bound  to  HSP47  for  a  much 
longer time in the ER compared to normally hydroxylated 
procollagen, as shown in Fig. 1. 
Thus, it was of interest to determine exactly when this 
chaperone-like protein binds to the procollagen polypep- 
tide chain and where it dissociates from its substrate, pro- 
collagen. In this report, we have examined whether HSP47 
can  bind  to nascent  procollagen  polypeptide chains,  and 
we have determined the sites within the cells where HSP47 
dissociates from procollagen using several inhibitors against 
procollagen  secretion.  The  binding  and  colocalization  of 
HSP47  with  procollagen  were  examined by immunopre- 
cipitation analysis combined with in vivo cross-linking, and 
by confocal microscopic observation after double labeling 
with anti-HSP47 and anticollagen antibodies, respectively. 
Short-term labeling of the  cells with  [35S]methionine  fol- 
lowed by immunoprecipitation with anti-HSP47  and anti- 
collagen antibodies revealed that HSP47 was bound to sin- 
gle nascent peptides that are sensitive to collagenase. This 
suggests that  HSP47  was bound  to  procollagen polypep- 
tide chains immediately after the procollagen had cotrans- 
lationally entered the ER as single cd(I) or c~2(I) polypep- 
tides. This conclusion is also supported by the coprecipitation 
of HSP47 and nascent collagenous polypeptides when the 
polysome-containing fraction of the cell lysates is precipi- 
tated with anti-HSP47  and  anticollagen antibodies  (Sauk 
et al., 1994). 
On the  other hand,  it is clear from the in  vitro experi- 
ments  that  HSP47  binds  to  collagens  that  have  already 
formed a triple helix (Nagata et al., 1986; Natsume et al., 
1994).  In this report, we have also shown  the  binding of 
HSP47 with mature triple-helix forms of procollagen (Fig. 
The Journal of Cell Biology, Volume 133, 1996  478 Figure 8.  The RDEL sequence at the COOH terminus of HSP47 acts as an ER-retention signal. The construct containing the RDEL- 
truncated  mutant  mouse HSP47 from its COOH terminus  (MH47~RDEL) was transfected by the calcium phosphate method into the 
CEFs. (A) The cells transfected with MH47ARDEL were preincubated in the presence (lanes 6-8) or absence (lanes I-5) of 5 txM mon- 
ensin, pulse labeled with 0.2 mCi/ml [35S]methionine for 30 min, and then chased in medium containing excess cold methionine for the 
indicated periods. After treatment with the lysis buffer, aliquots of the cell extract were immunoprecipitated with the rabbit anti-mouse 
HSP47 antibody. The immunocomplexes were subsequently analyzed by SDS-PAGE and autoradiography.  (B) Time course of the se- 
cretion of MH47ARDEL transfected and expressed in CEFs. Culture medium from A  was collected after 30 or 60 min of chase, immu- 
noprecipitated with the anti-mouse HSP47  antibody, and then analyzed by SDS-PAGE. (C) MH47ARDEL secreted into the culture 
medium was sensitive to endo H treatment. The immunocomplexes in B were treated with or without 55 U/ml of endo H  at 37°C for 12 h, 
and were then applied to an SDS-8% polyacrylamide gel. MH47ARDEL  s is the form digested by endo H. 
10).  In the future, we will examine whether HSP47 binds 
to  nascent  single-polypeptide  chains  as  an  early  event, 
with interactions continuing during the folding and triple- 
helix formation of procollagen. The possibility must also 
be considered that HSP47 binds independently to mono- 
meric polypeptide chains and to mature triple-helical forms 
of procollagen. 
In other  experiments,  we  examined  where  the  HSP47 
dissociates from procollagen within the cells. The inhibition 
of procollagen secretion in the ER induced by c~, a'-dipyr- 
idyl or by the depletion of ascorbate did not cause any dis- 
sociation  of  HSP47  from  procollagen.  Brefeldin  A  has 
been  reported  to  inhibit  protein  secretion  and  dramati- 
cally disintegrate the Golgi apparatus, resulting in the re- 
distribution of Golgi membranes in the ER. Uncoated tu- 
bules  emanating  from  the  Golgi  complex  are  observed 
rapidly after the  addition  of brefeldin A, suggesting that 
they are the structural  intermediates that carry the Golgi 
membranes  to  the  ER.  The  intermediate  compartment, 
however, is shown to remain intact in brefeldin A-treated 
cells  (Lippincott-Schwartz  et  al.  1989,  1990;  Klausner  et 
al., 1992).  The immediate effect of brefeldin A  is to pre- 
vent nucleotide exchange, thereby preventing ARF bind- 
ing to the  Golgi membrane and subsequent ARF-depen- 
dent assembly of coated vesicles (Donaldson et al.,  1992; 
Tanigawa et al., 1993).  Thus, brefeldin A  would block an- 
terograde traffic from ER and Golgi without affecting ret- 
rograde transport from Golgi complex to ER (Klausner et 
al., 1992). 
Treatment of the cells with brefeldin A  or at a low tem- 
perature  (15°C)  did  not cause the  dissociation of HSP47 
from procollagen, which was examined biochemically by 
coprecipitation analysis using either antibody. These treat- 
ment paradigms caused the accumulation of small vesicles, 
where both HSP47 and procollagen were colocalized, al- 
though most of the HSP47 that did not associate with pro- 
collagen  remained in the  ER.  Similar small vesicles that 
were identified as the intermediate compartment were re- 
ported  to  be  observed  after  treatment  of the  cells  with 
brefeldin A  or at  15°C  (Lippincott-Schwartz et al.,  1989, 
1990).  These small vesicles, which were distinct  from the 
ER, disappeared after removing brefeldin A  from the me- 
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scent  single  polypeptide chains 
of procollagen.  CEFs were cul- 
tured  in  medium  containing  5 
p~g/ml ascorbate  phosphate  for 
12 h. Immediately after pulse la- 
beling with 0.2 mCi/ml  [35S]me- 
thionine  for  10  min,  the  ceils 
were collected, incubated without 
(lanes  1-4)  or  with  (lanes  58) 
the cross-linking  reagent for 30 
min at  0°C, and were then  ex- 
tracted by the addition  of lysis 
buffer  without  (lanes  1--4) or 
with (lanes 5--8) 0.5 mg/ml gela- 
tin.  Aliquots  of the cell extract 
were mixed with the rabbit anti- 
HSP47  antibody (lanes  1, 2,  5, 
and 6) or with  the rabbit anti- 
type I collagen antiserum (lanes 
3, 4, 7, and 8). The immunocom- 
plexes  were  incubated  with  or 
without  20 U/ml collagenase  for 
30 min at 37°C, and were then 
eluted  with  the  SDS  sample 
buffer.  The  immunocomplexes 
were  analyzed  by  8%  SDS- 
PAGE  under  nonreducing  (A) 
and reducing (B) conditions. (C- 
propeptide)3,  the  C-propeptide 
of  procollagen  that  was  cross- 
linked  by intermolecular disul- 
fide  bonds  between  the  three 
procollagen  chains.  Bracket, 
procollagen  bands  digested  with 
collagenase. 
dium or upon returning the temperature to 37°C. Since the 
anti-p53  antibody  (Schweizer  et  al.,  1988)  did  not  react 
with CEFs, we could not identify these vesicles as interme- 
diate  compartments. However, the  above mentioned  ex- 
perimental results strongly suggest that these vesicles were 
intermediate compartments. Thus, it is probable that pro- 
collagen does not dissociate from HSP47 neither in the ER 
nor  in  the  intermediate  compartment.  Recently,  Ham- 
mond and Helenius (1994b) showed that the misfolded G 
protein  of the  temperature-sensitive  vesicular  stomatitis 
virus tsO45 is associated with both calnexin and BiP/GRP78, 
but  moves  to  the  intermediate  compartment  only  with 
BiP/GRP78. In this report, it was demonstrated that when 
the secretory pathway was blocked with brefeldin A, the 
complex of normal folded procollagen with HSP47  (and 
perhaps with PDI as well) accumulated in the intermedi- 
ate compartment. We will try to identify whether there are 
other chaperone proteins contained in these small vesicles. 
When the cells were treated with monensin or bafilomy- 
cin  A1,  the  dissociation of HSP47 from procollagen  was 
clearly observed, whereas the secretion of procoUagen was 
inhibited. Monensin is a well-characterized ionophore that 
binds Na  ÷, K ÷, and protons (Tartakoff, 1983).  Bafilomycin 
A1 is a specific inhibitor for the vacuolar-type H ÷ ATPase, 
and  it  is  known  to  inhibit  the  secretion  of the  proteins 
from the trans-Golgi network (Umata et al., 1990; Yoshi- 
mori et al.,  1991;  Henomatsu et al.,  1993).  Treatment of 
the cells with monensin inhibits the intracellular transport 
of  newly  synthesized  plasma  membrane  proteins  and 
secretory proteins, including  procoUagens and proteogly- 
cans, within the Golgi complex (Uchida et al., 1979; Tarta- 
koff, 1983).  Although monensin may have multiple sites of 
action depending on the cell type, our results suggest that 
monensin inhibited translocation between the cis- and me- 
dial-Golgi compartments because the accumulated procol- 
lagen was colocalized with p58 (a Golgi marker) and mon- 
ensin-inhibited fibronectin was endo H  sensitive (data not 
shown). Thus, HSP47 must have been dissociated from the 
procoUagen between intermediate compartment (cis-Golgi 
network) and the cis-Golgi  compartment. This is the first 
report  identifying  where  a  molecular chaperone  protein 
dissociates from its substrate in the central secretory pathway. 
Dissociation of HSP47  from Procollagen 
Molecular  chaperones  such  as  HSP70  and  GroEL  are 
known to have ATP binding and weak ATPase activities 
(Chandrasekhar et al., 1986;  Liberek et al., 1991). HSP70 
is now thought to dissociate from its substrates by chang- 
ing its affinity for them after it binds ATP (Palleros et al., 
1994). However, HSP47 has neither ATP-binding nor ATP- 
ase activities (Nagata, K., and M. Satoh, unpublished ob- 
servation).  It  is  therefore  of  interest  to  elucidate  how 
HSP47  dissociates  from  procollagen.  Previously,  we  re- 
The Journal of Cell Biology,  Volume 133, 1996  480 Figure 10.  HSP47 binds to the trypsin-resistant  triple helix form of procollagen.  CEFs were cultured  in the medium containing 5 ixg/ml 
ascorbate phosphate for 12 h, and were preincubated in either 2 p,g/ml brefeldin A or in 0.3 mM et, et'-dipyrydyl for 30 min. The cells 
were pulse labeled with 0.167 mCi/ml [3H]proline for 30 min, and were then chased for 30 or 60 min in medium containing  excess cold 
proline.  Cross-linking and immmunoprecipitation were performed as described in Materials  and Methods. The immunocomplexes pre- 
cipitated with the anti-HSP47 antibody (A) or the anti-type I collagen antibody (B) were treated with (lanes 1--6) or without (lanes 7-12) 
20 ixg/ml  trypsin for 4 min at 37°C, and were then applied to an SDS-8% polyacrylamide gel. 
ported  that  HSP47  dissociates  from  collagen  when  the 
buffer pH is lowered to pH 6.3 in an in vitro binding assay 
using collagen-coupled Sepharose 4B affinity beads (Saga 
et  al.,  1987),  and  that  the  coprecipitation  of procollagen 
with HSP47 decreases in pH 6.0 buffer (Nakai et al., 1990, 
1992).  When  the  cells  are  treated  with the  proton  iono- 
phore  carbonyl  m-chlorophenylhydrazone  (CCCP)  in  a 
low pH (pH 6.3)  medium, the coprecipitation  of procol- 
lagen with HSP47 is decreased (Nakai et al., 1992).  These 
results show that the dissociation of HSP47 from collagen 
can be regulated by pH. We have reported very recently, 
however, that  the  majority of HSP47  bound  to  collagen 
dissociates in a pH-independent but concentration-depen- 
dent manner in an in vitro binding analysis using surface 
plasmon resonance, the BIAcore system (Natsume et al., 
1994).  According to the results obtained by surface plas- 
mon resonance,  the  dissociation constants  of HSP47  for 
types  I-IV collagens  ranges  from  10  -7  to  10  -6  M,  and 
HSP47  dissociates  very rapidly from collagen  molecules 
once  the  free HSP47  concentration  in  the  flow buffer is 
lowered (the dissociation rate constant of HSP47 for type I 
collagen is 2.36 ×  10  -2 s-i). 
Considering  these  results  obtained  from both  in  vitro 
and  in  vivo experiments,  the  intracellular  interaction  of 
HSP47  with  newly synthesized  collagen molecules could 
be outlined as follows. Immediately after single chains of 
procollagen cotranslationally enter the ER, HSP47 binds 
to these single polypeptide chains. Since the type I procol- 
lagen  forms  a  triple  helix  at  the  COOH  terminus,  the 
newly synthesized polypeptide chains need to be protected 
from being folded or aggregated until the completion of 
translation.  The  binding  of HSP47  to  the  newly synthe- 
sized single chains  might be beneficial in preventing the 
folding or the aggregation of these nascent polypeptides. 
As  we  previously  reported,  other  ER-resident  proteins 
such as GRP78/BiP and PDI might be involved in the for- 
mation of these  complexes because these  three  ER pro- 
teins  (BiP,  PDI, and HSP47)  form a  complex in the  ER 
(Nakai et al., 1992).  HSP47 remains bound to these triple 
helices of procollagen in the ER, as well as in the transport 
vesicles.  Recently,  we  determined  stoichiometry  of  the 
binding of recombinant mouse HSP47 to type I  collagen 
using surface plasmon resonance (Natsume, T., and K. Na- 
gata,  unpublished  observations); more than  seven mole- 
cules of HSP47 bind to a  single triple helix of type I  col- 
lagen. Although the physiologic role of HSP47 binding to 
procollagen in the above processes is obscure, there is the 
possibility that HSP47 is involved in the processing of pro- 
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transport  of the  procollagen from the  ER  to  the  Golgi 
compartments.  Alternatively, HSP47  (colligin) has  been 
reported recently to have an inhibitory action against the 
degradation of procollagens in the ER (Jain et al., 1994). 
This is more conceivable considering the similarity in the 
primary structures of HSP47 and the serpin (serine pro- 
tease inhibitor) super family (Hirayoshi et al., 1991; Take- 
chi et al., 1992). 
When  the  HSP47/procollagen complex enters  the cis- 
Gotgi compartment, the concentration of free HSP47 de- 
creases rapidly since HSP47 might be retrogradely trans- 
ported back from the Golgi to ER via a retrieval flow with 
KDEL receptors. KDEL receptors are found to be con- 
centrated mainly in the Golgi membranes (Semenza et al., 
1990; Lewis and Pelham, 1990; Tang et al., 1993), and we 
have clearly confirmed in the present work that the RDEL 
sequence at the COOH terminus of HSP47 actually acts as 
an ER-retention signal by deleting this sequence from the 
HSP47 cDNA. Although we have not confirmed whether 
the RDEL sequence is actually recognized by KDEL re- 
ceptors, the possible scavenging of HSP47 from the Golgi 
compartment may cause the absence of free HSP47 there, 
which  was  confirmed  by  immunoelectron  microscopy 
(Saga et al., 1987; Kambe et al., 1994). This rapid decrease 
in the free HSP47 concentration could cause the rapid dis- 
sociation of HSP47 from procollagen molecules in the cis- 
Golgi compartment because of their high dissociation rate 
constant (Kd  =  10 -2 s-l; Natsume et al.,  1994).  Although 
we clearly observed the pH-dependent dissociation of col- 
lagen  from HSP47  in  in  vitro experiments  (Saga  et  al., 
1987; Nakai et al., 1992), we cannot confirm at the present 
time whether this pH-dependent dissociation actually oc- 
curs in vivo. Since the pH in the trans-Golgi compartment 
is  known  to fall as  low as pH  5.7  (Anderson and  Orci, 
1988; Wilson et al., 1993), it should be interesting to deter- 
mine whether a small portion of the HSP47 is transported 
into  the  trans-Golgi  cisternae  with  procollagen  and 
whether it dissociates there from procollagen in a pH-depen- 
dent manner. 
Correlational Expression of liSP47 with 
Collagen Genes 
As  a  possible  molecular  chaperone,  HSP47  should  be 
closely related to collagen processing and/or secretion, as 
well as to the inhibition of procollagen degradation in the 
ER. In addition to these functions, the expression of HSP47 
is always closely correlated with the expression of the vari- 
ous types of collagens. In fibroblasts, the synthesis of both 
HSP47 and type I collagen decreases after malignant trans- 
formation by  Rous  sarcoma  virus  (Nagata  et  al.,  1986; 
Clarke et al., 1993), simian virus 40 (Nakai et al., 1990), and 
the activated c-Ha-ras oncogene (Nagata et al., 1991).  In 
contrast, both HSP47 and type IV collagen synthesis in- 
crease markedly during the differentiation of the mouse 
teratocarcinoma cell line F9 after treatment with retinoic 
acid alone or with retinoic acid plus dibutyryl cAMP (Kur- 
kinen et al., 1984; Takechi et al., 1992). Interestingly, HSP47 
synthesis is not observed in cells where collagen synthesis 
is not detected, such as mouse myeloid leukemic M1 cells 
and mouse pheochromocytoma PC12 cells (Nagata et al., 
1991). Such a correlation between the expression of HSP47 
and several types of collagen has also been reported in rat 
cells (Clark et al., 1993). We also observed a strong corre- 
lation  in  the  regulation  of HSP47  with  collagen  under 
pathological conditions in vivo: the synthesis of HSP47, as 
well as type I and III collagens, are dramatically increased 
during the progression of rat liver fibrosis induced by car- 
bon tetrachloride (Masuda et al., 1994).  In situ hybridiza- 
tion analysis shows that only cells adjacent to the collagen 
fibrils  in  the  carbon  tetrachloride-treated  rat  liver  ex- 
pressed large amounts of HSP47 mRNA, whereas cells far 
from the collagen fibrils did not. Thus, HSP47 is the stress 
protein that has substrate specificity, and the regulation of 
which  is  also  closely correlated with  this  substrate,  col- 
lagen. 
Such a correlation in the expression between HSP47 and 
various collagens is also observed during the development 
of the mouse embryo. For example, HSP47 is strongly ex- 
pressed in cartilaginous regions, especially in chondrocytes 
in  the  proliferation and  maturation  zones of epiphyseal 
growth  plates,  where  the  expression of type II collagen 
was also prominent. In contrast, both type I collagen and 
HSP47 were localized to the extracellular matrix and os- 
teoblasts  in  the  vascularization zone  during  ossification 
(Masuda,  H.,  and  K.  Nagata,  manuscript  submitted  for 
publication).  Kambe  et  al.  (1994)  also  reported  that 
HSP47 was expressed in the epiphyseal cartilage and  in 
cultured chondrocytes from chick embryos. These correla- 
tions in the expression of HSP47 with various types of col- 
lagen suggest an important role for HSP47 in the process- 
ing and/or secretion of collagens in various types of cells. 
The mechanism of HSP47 induction with respect to col- 
lagen formation, as well as the function of HSP47 as a mo- 
lecular chaperone specific for collagen, still  remain to be 
elucidated in detail in the near future. 
We are grateful to Dr. T. Yoshimori (Kansai Medical University) for pro- 
viding us with anti-PDl antibody. 
This work was partially supported by Grant-in-Aids for Scientific Re- 
search on Priority Areas from the Ministry of Education, Science and Cul- 
ture, Japan, and by a grant from the Naitoh foundation. 
Received for publication 17 April 1995  and  in revised form  2  January 
1996. 
References 
Anderson, R.G.,  and L.  Orci.  1988. A  view of acidic intracellular compart- 
ments. J. Cell BioL  160:539-543. 
Bloom, G.S., and T.A. Brachear.  1989. A novel 58-kDa protein associates with 
the Golgi apparatus and microtubules. J. Cell Biol. 264:16083-16092. 
Chandrasekhar, G.N., K. Tilly, C. Woolford.  R. Hendrix, and C. Georgopoulos. 
1986. Purification and properties of the groES morphogenetic protein of Es- 
cherichia coli. J. Biol. Chem. 261:12414-12419. 
Chessler, S.D., and P.H. Byers. 1993. BiP binds type I procollagen proa chains 
with mutations in the carboxyl-terminal propeptides synthesized by cells 
from patients with osteogenesis  imperfecta. J. Biol.  Chem. 268:18226-18233. 
Chessler,  S.D., G.A. Wallis, and P.H. Byers.  1993. Mutations in the carboxyl- 
terminal propeptide of the prot~l(I) chain of type I collagen result in defec- 
tive chain association  and produce lethal osteogenesis imperfecta.  J.  Biol. 
Chem. 268:18218-18225. 
Clarke, E.P., N. Jain, A. Brickenden, I.A. Lorimer, and B.D. Sanwal. 1993. Par- 
allel regulation of procollagen I and colligin, a collagen-binding  protein and 
a member of the serine protease inhibitor family. J. Cell BioL  121:193-199. 
De Silva, A., I. Braakman, and A. Helenius.  1993. Posttranslational folding of 
vesicular stomatitis virus G protein in the ER: involvement of noncovalent 
and covalent complexes.,/.  Cell Biol.  120:647~555. 
De Silva, A.M., W.E. Balch, and A. Helenius.  1990. Quality control in the endo- 
plasmic reticulum: folding and misfolding  of vesicular  stomatitis  virus G pro- 
tein in cells and in vitro. J. Cell Biol.  111:857-866. 
The Journal of Cell Biology, Volume  133, 1996  482 Donaldson,  J.G.,  D.  Finazzi, and R.D.  Klausner.  1992.  Brefeldin A  inhibits 
Golgi membrane-catalysed exchange of guanine nucleotide onto ARF pro- 
tein. Nature (Loud.). 360:350-352. 
Donaldson,  J.G.,  J.  Lippincott-Schwartz, G.S.  Bloom, T.E.  Kreis,  and R.D. 
Klausner. 1990. Dissociation of a 110-kD peripheral membrane protein from 
the Golgi apparatus is an early event in brefeldin A action. J. Cell Biol. 111: 
2295-2306. 
Duden, R., M. Hosobuchi, S. Hamamoto, M. Winey, B. Byers, and R. Schek- 
man. 1994. Yeast 13- and 13'-coat proteins (COP). J. Biol.  Chem. 269:24486- 
24495. 
Gething, M.-J., and J. Sambrook. 1992. Protein folding in the cell. Nature (Lond). 
355:33-45. 
Hammond, C., and A. Helenius. 1994a.  Folding of VSV G  protein: sequential 
interaction with BiP and calnexin. Science (Wash. DC). 266:456-458. 
Hammond, C., and A. Helenius. 1994b.  Quality control in the secretory path- 
way: retention of a misfolded viral membrane glycoprotein involves cycling 
between the ER, intermediate compartment, and Golgi apparatus. J.  Cell 
Biol. 126:41-52. 
Henomatsu, N., T. Yoshimori, A. Yamamoto, Y. Moriyama, and Y. Tashiro. 
1993. Inhibition of intracellular transport of newly synthesized prolactin by 
bafilomycin A1 in a pituitary tumor cell line, GH3 cells. Eur J. Cell Biol. 62: 
127-139. 
Hirayoshi, K., H. Kudo, H. Takechi, A. Nakai, A. Iwamatsu, K.M. Yamada, 
and K. Nagata. 1991. HSP47: a tissue-specific, transformation-sensitive, col- 
lagen-binding heat shock protein of chicken embryo fibroblasts. Mol.  Cell. 
Biol. 11:4036-4044. 
Hurtley, S.M.,  and A. Helenius. 1989. Protein oligomerization in the endoplas- 
mic reticulum. Annu. Rev. Cell Biol. 5:277-307. 
Hurtley, S.M.,  D.G.  Bole, H. Hoover-Litty, A. Helenius, and C.S.  Copeland. 
1989. Interactions of misfolded influenza virus hemagglutinin with binding 
protein (BiP). J. Cell Biol. 108:2117-2126. 
Jackson, M.R.,  T.  Nilsson, and P.A.  Peterson.  1993.  Retrieval of transmem- 
brane proteins to the endoplasmic reticulum. J. Cell Biol. 121:317-333. 
Jain, N., A. Brickenden, E.H. Ball, and B.D. Sanwal. 1994. Inhibition of procol- 
lagen I degradation by colligin: a collagen-binding serpin. Arch.  Biochem. 
Biophys. 314:23-30. 
Kambe, K., A. Yamamoto, T. Yoshimori, K. Hirayoshi, R. Ogawa, and Y. Tash- 
iro. 1994. Preferential localization of heat shock protein 47 in dilated endo- 
plasmic reticulum of chick chondrocytes. Z Histochem. Cytochem. 42:833~841. 
Klausner, R.D., J.G. Donaldson, and J. Lippincott-Schwartz. 1992. Brefeldin A: 
insights into the control of membrane traffic and organelle structure. J.  Cell 
Biol. 116:1071-1080. 
Koivu, J., and R. Myllyla. 1987. Interchain disulfide bond formation in type I 
and II procollagen. J. Biol. Chem. 262:6159-6164. 
Kornfeld, R., and S. Kornfeld. 1985. Assembly of asparagine-linked oligosac- 
charides. Ann. Rev. Biochem. 54:631-664. 
Kozutsumi,  Y.,  M.  Segal, K.  Normington, M.-J.  Gething, and J.  Sambrook. 
1988. The presence of malfolded proteins in the endoplasmic reticulum sig- 
nals the induction of glucose-regulated proteins. Nature  (Lond.).  332:462- 
464. 
Ktistakis, N.T., M.G. Roth, and G.S. Bloom. 1991. PtK1 cells contain a nondif- 
fusible, dominant factor that makes the Golgi apparatus resistant to brefeldin 
A.J. Cell Biol. 113:1009-1023. 
Kurkinen, M., A. Taylor, J.I. Garrels, and B.L. Hogan. 1984. Cell surface-asso- 
ciated proteins which bind native type IV collagen or gelatin. J. Biol. Chem. 
259:5915-5922. 
Lewis, M.J.,  and H.R.B. Pelham. 1990. A human homologue of the yeast HDEL 
receptor. Nature (Lond.). 348:162-163. 
Lewis, M.J., and H.R.B. Pelham. 1992. Ligand-induced redistribution of a hu- 
man KDEL receptor from the Golgi complex to the endoplasmic reticulum. 
Cell. 68:353-364. 
Liberek, K., J. Marszalek, D. Ang, C. Georgopoulos, and M. Zylicz. 1991. Es- 
cherichia coli DnaJ and GrpE heat shock proteins jointly stimulate ATPase 
activity of DnaK. Proc. Natl. Acad. Sci. USA. 88:2874-2878. 
Lippincott-Schwartz,  J.,  J.G.  Donaldson,  A.  Schweizer,  E.G.  Berger,  H.-P. 
Hauri, L.C. Yuan, and R.D. Klausner. 1990. Microtubule-dependent retro- 
grade transport of proteins into the ER in the presence of brefeldin A  sug- 
gests an ER recycling pathway. Cell. 60:821-836. 
Lippincott-Schwartz, J., L.C. Yuan, J.S.  Bonifacino, and R.D. Klausner. 1989. 
Rapid  redistribution of Golgi proteins into the  ER in cells treated with 
brefeldin A: evidence for membrane cycling from Golgi ER. Cell  56:801- 
813. 
Masuda, H., M. Fukumoto, K. Hirayoshi, and K. Nagata. 1994. Coexpression of 
the collagen-binding stress protein HSP47 gene and the cd(I) and cd(III) 
collagen genes in carbon tetrachloride-induced rat liver fibrosis. J. Clin. In- 
vest. 94:2481-2488. 
Melnick, J., S.  Aviel, and Y. Argon.  1992. The endoplasmic reticulum stress 
protein grp94, in addition to BiP, associates with unassembled immunoglob- 
ulin chains. Z BioL Chem. 267:21303-21306. 
Melnick, J., J.L. Dul, and Y. Argon. 1994. Sequential interaction of the chaper- 
ones BiP and grp94 with immunoglobulin chains in the endoplasmic reticu- 
lum. Nature (Lond.). 370:373-375. 
Munro, S., and H.R.B. Pelham. 1987. A  c-terminal signal prevents secretion of 
luminal ER proteins. Cell. 48:899-907. 
Nagata, K., K. Hirayoshi, M. Obara, S. Saga, and K.M. Yamada. 1988. Biosyn- 
thesis of a novel transformation-sensitive heat-shock protein that binds to 
collagen. J. Biol. Chem. 263:8344-8349. 
Nagata, K., A. Nakai, N. Hosokawa, H. Kudo, H. Takechi, M. Satoh, and K. 
Hirayoshi. 1991. Interaction of HSP47 with newly synthesized procollagen, 
and regulation of HSP expression. In Heat Shock. B. Maresca and S. Lin- 
doquist, editors. Springer-Verlag, New York. 105-110. 
Nagata, K., S. Saga, and K.M. Yamada. 1986. A major collagen-binding  protein 
of chick embryo fibroblasts is a novel heat shock protein. J.  Cell BioL  103: 
223-229. 
Nakabeppu, Y., S. Oda, and M. Sekiguchi. 1993. Proliferative activation of qui- 
escent rat-lA cells by AFosB. Mol. Cell.  Biol. 13:4157-4166. 
Nakai, A., K.  Hirayoshi, and K. Nagata. 1990. Transformation of BALB/3T3 
cells by simian virus 40 causes a decreased synthesis of a collagen-binding 
heat-shock protein (hsp74). J. Biol. Chem. 265:992-999. 
Nakai, A., M. Satoh, K. Hirayoshi, and K. Nagata.  1992. Involvement of the 
stress protein HSP47 in procollagen processing in the endoplasmic reticu- 
lum. J. Cell Biol. 117:903-914. 
Natsume, T., T. Koide, S. Yokota, K. Hirayoshi, and K. Nagata. 1994. Interac- 
tions between collagen-binding stress protein HSP47 and collagen. J.  Biol. 
Chem. 269:31224-31228. 
Nilsson, T., M.R. Jackcon, and P.A. Peterson. 1989. Short cytoplasmic sequences 
serve as retention signals for transmembrane proteins in the endoplasmic 
reticulum. Cell.  58:707-718. 
Palleros, D.R., L. Shi, K.L. Reid, and A.L. Fink. 1994. hsp70-protein complexes. 
J. Biol. Chem. 269:13107-13114. 
Rosa, P., S. Mantovani, R. Rosboch, and W.B. Huttner.  1992. Monensin and 
brefeldin A  differentially affect the phosphorylation and sulfation of secre- 
tory proteins. J. BioL Chem. 267:12227-12232. 
Rosenbloom, J.,  R.  Endo, and M.  Harsch.  1976.  Termination of procollagen 
chain synthesis by puromycin. J. Biol. Chem. 251:2070--2076. 
Saga, S., K. Nagata, W.-T. Chen, and K.M. Yamada. 1987. pH-dependent func- 
tion, purification, and intracellular location of a major collagen-binding gly- 
coprotein. A Cell Biol. 105:517-527. 
Saiki, R.K., D.H. Gelfand, S. Stoffel, S.J. Scharf, R. Higuchi, G.T. Horn, K.B. 
Mullis, and H.A. Erlich. 1988. Primer-directed enzymatic amplification  of DNA 
with a thermostable DNA polymerase. Science (Wash. DC). 239:487-491. 
Saraste, J., and K. Svensson. 1991.  Distribution of the intermediate elements 
operating in ER to Golgi transport. J. Cell Sci.  100:415-430. 
Sauk, J.J., T. Smith, K. Norris, and L. Ferreira. 1994. Hsp47 and the translation- 
translocation machinery cooperate in the production of cO(l) chains of type 
I procollagen. J. Biol. Chem. 269:3941-3946. 
Schweizer, A., J.A. Fransen, T. Bachi, L. Ginsel, and H.-P. Hauri. 1988. Identi- 
fication, by a monoclonal antibody, of a 53-kD protein associated with a tu- 
bulovesicular compartment at the  cis-side  of the Golgi apparatus. J.  Cell 
Biol. 107:1643-1653. 
Schweizer, A., J.A.M.  Fransen, K.  Matter, T.E.  Kreis,  L.  Ginsel, and H.-P. 
Hauri. 1990. Identification of an intermediate compartment involved in pro- 
tein transport from endoplasmic reticulum to Golgi apparatus. Eur. A  Cell Biol. 
53:185-196. 
Semenza, J.C.,  K.G.  Hardwick, N.  Dean,  and  H.R.B.  Pelham.  1990.  ERD2, 
yeast gene required for the receptor-mediated retrieval of luminal ER pro- 
teins from the secretory pathway. Cell 61:1349-1357. 
Takechi, H., K. Hirayoshi, H. Kudo, S. Saga, and K. Nagata. 1992. Molecular 
cloning of a mouse 47-kda heat shock protein (HSP47), a collagen-binding 
stress protein, and its expression during the differentiation of F9 teratocarci- 
noma cells. Eur. A  Biochem. 206:323-329. 
Tang, B.L., S.H. Wong, X.L. Qi, S.H. Low, and W. Hong. 1993. Molecular clon- 
ing, characterization, subcellular localization and dynamics of p23, the mam- 
malian KDEL receptor. J. Cell Biol. 120:325-338. 
Tanigawa, G., L. Orci, M. Amherdt, M. Ravazzola, J.B. Helms, and J.E. Roth- 
man. 1993. Hydrolysis of bound GTP by ARF protein triggers uncoating of 
Golgi-derived COP-coated vesicles. J.  Cell Biol. 123:1365-1371. 
Tartakoff, A.M. 1983. Perturbation of vesicular traffic with the carboxylic iono- 
phore monensin. Cell. 32:1026-1028. 
Uchida, N., H. Smilowitz, and M.L. Tanzer.  1979. Monovalent ionophores in- 
hibit secretion of procollagen and fibronectin from cultured human fibro- 
blasts. Proc. Natl. Acad. Sci.  USA. 76:1868-1872. 
Umata, T., Y. Moriyama, M. Futai, and E. Mekada. 1990. The cytotoxic action 
of diphtheria toxin and its degradation in intact vero cells are inhibited by 
bafilomycin A1, a  specific inhibitor of vacuolar-type H+-ATPase. J.  BioL 
Chem. 265:21940-21945. 
Wilson, D.W, M.J. Lewis, and H.R.B. Pelham. 1993. pH-dependent binding of 
KDEL to its receptor in vitro. J. Biol. Chem. 268:7465-7468. 
Yoshimori, T., A Yamamoto, Y. Moriyama, M. Futai, and Y. Tashiro. 1991. Ba- 
filomycin A1, a specific inhibitor of vacuolar-type H+-ATPase, inhibits acid- 
ification and protein  degradation in lysosomes of cultured cells. J.  Biol. 
Chem. 266:17707-17712. 
Satoh et al. Interaction of liSP47 with Procollagen  483 